Log in to save to my catalogue

New Biomarkers of Ferric Management in Multiple Myeloma and Kidney Disease-Associated Anemia

New Biomarkers of Ferric Management in Multiple Myeloma and Kidney Disease-Associated Anemia

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6912471

New Biomarkers of Ferric Management in Multiple Myeloma and Kidney Disease-Associated Anemia

About this item

Full title

New Biomarkers of Ferric Management in Multiple Myeloma and Kidney Disease-Associated Anemia

Publisher

Switzerland: MDPI

Journal title

Journal of clinical medicine, 2019-11, Vol.8 (11), p.1828

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI

Subjects

Subjects and topics

More information

Scope and Contents

Contents

Multiple myeloma (MM) is a malignancy of clonal plasma cells accounting for approximately 10% of haematological malignancies. MM mainly affects older patients, more often males and is more frequently seen in African Americans. The most frequent manifestations of MM are anaemia, osteolytic bone lesions, kidney failure and hypercalcemia. The anaemia...

Alternative Titles

Full title

New Biomarkers of Ferric Management in Multiple Myeloma and Kidney Disease-Associated Anemia

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6912471

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6912471

Other Identifiers

ISSN

2077-0383

E-ISSN

2077-0383

DOI

10.3390/jcm8111828

How to access this item